Matrices listed below were spiked with certain level of TDG1/CFC-2/TDGF1/TDGF-1/CR/Cripto-1/Cripto-1 growth factor/CRIPTOCRGF/Epidermal growth factor-like cripto protein CR1/teratocarcinoma-derived growth factor 1 and the recovery rates were calculated by comparing the measured value to the expected amount of TDG1/CFC-2/TDGF1/TDGF-1/CR/Cripto-1/Cripto-1 growth factor/CRIPTOCRGF/Epidermal growth factor-like cripto protein CR1/teratocarcinoma-derived growth factor 1 in samples.
Matrix
Recovery range(%)
Average(%)
serum(n=5)
85-105
92
EDTA plasma(n=5)
95-105
98
heparin plasma(n=5)
86-101
92
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of TDG1/CFC-2/TDGF1/TDGF-1/CR/Cripto-1/Cripto-1 growth factor/CRIPTOCRGF/Epidermal growth factor-like cripto protein CR1/teratocarcinoma-derived growth factor 1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.